Valeant Pharmaceuticals International (VRX) said its wholly owned subsidiary, Valeant Canada Limited, has agreed to acquire Laboratoire Dr. Renaud, a cosmeceutical company located in Canada for approximately C$23 million. The transaction is expected to be accretive in 2010.
Further, as part of the transaction, Valeant will also enter into a lease for a 45 thousand square foot facility that includes a manufacturing plant completed in 2007 specializing in topical formulations.
The transaction is expected to occur before the end of the year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.